the microvascular disease conundrum

19
THE MICROVASCULAR DISEASE CONUNDRUM: WHO SHOULD I REFER FOR EVALUATION, WHAT TESTS WILL THEY PERFORM, AND WHAT TREATMENTS MIGHT THEY OFFER Jennifer A Tremmel, MD, MS Stanford University Medical Center

Upload: others

Post on 02-Apr-2022

3 views

Category:

Documents


0 download

TRANSCRIPT

THE  MICROVASCULAR  DISEASE  CONUNDRUM:

WHO  SHOULD   I  REFER  FOR  EVALUAT ION ,  WHAT  TESTS  WILL  THEY  PERFORM,  AND  WHAT  TREATMENTS  MIGHT  

THEY  OFFER

Jennifer A Tremmel, MD, MSStanford University Medical Center

Disclosures

Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below

Abbott: Advisory Boards, Honorarium Boston Scientific: Advisory Boards, Honorarium, Research Terumo: Honorarium

Microvascular Dysfunction (MVD) Angina + normal cors ≠ MVD Angina + normal cors = several different etiologies MVD can be used as a working diagnosis and one can try

empiric treatment, but if not helping, consider testing There are different testing options for MVD

– Non-invasive and invasive MVD is evolving as a broader term for disorders of the

coronary microvasculature– Structural=plugged up, loss of density/Functional=dysregulation of vasomotion

MVD occur in obstructive/non-obstructive CAD, as well as SIHD/ACS

INOCA (Ischemia and non-obstructive coronary arteries)

4 INOCA Endotypes1. Microvascular angina (MVA, structural/functional)2. Vasospastic angina (VSA, epicardial spasm)3. Mixed MVA/VSA4. Non-cardiac5. Myocardial bridging (the forgotten endotype)

Ford et al. Circ Cardiovasc Interv 2019;12:e008126Lee, Tremmel, et al. Circulation 2015;131:1054‐60Pargaonkar, Tremmel, et al. EuroIntervention 2021;16:1070‐1078

Who are these patients? Usually normal people with typical (62%) or atypical (38%) angina for

>3 months (more commonly years)—more often women than men (3:1)

Don’t have other causes of angina (pulmonary hypertension, hypertrophic/other cardiomyopathy, valvular heart disease, myopericarditis, etc)

They’ve typically had at least one, and generally multiple stress tests, and often coronary angiography (≥1x)

They’ve generally been tried on several cardiac medications

They have been told nothing is wrong, but they continue to be limited by angina

Stress testing inadequate Conventional stress testing is inadequate in identifying occult coronary

abnormalities (endothelial and microvascular dysfunction) Cannot reassure a patient based on a stress test May be helpful in identifying the presence of a myocardial bridge (focal

septal buckling with apical

Cassar et al. Circ Cardiovasc Interv. 2009;2(3):237‐44 Lin, Tremmel, et al. JAHA 2013;2:e00009Pargaonkar, Tremmel, et al. Int J Cardiol 2019;282:7–15

Case

50 yo perimenopausal woman with no significant cardiac risk factors who has had chest pain for ~3 years

Reports that chest pain has been progressive over time to now daily Describes chest pain as occurring both with exertion and at rest (often

with emotional stress), and associated with dyspnea– Negative stress test– Negative angiogram– Multiple ER visits– Initially told that her symptoms were anxiety, then MVD/spasm– Tried on amlodipine, nitrate, and Coreg, with no significant change in

symptoms

What tests get done? Testing varies by:

– What is done—Epicardial spasm only, MVD only, IVUS, myocardial bridge testing

– What wires are used—Doppler wire, thermodilution wire, no wire– What drugs are used—Ach, ergonovine, adenosine, dobutamine/atropine

(and in what order)– How the drugs are given—IV, IC, through guide vs microcatheter, bolus vs

infusion– What doses are used—Ach (20mcg to 200 mcg), for example

Pargaonkar, Tremmel et al. Int J Cardiol 2019;282:7–15Pargaonkar, Tremmel et al. Circ Cardiovasc Intrv 2020;13:e008587

Femoral access, no obstructive CAD

Ach testing

The patient developed chest pain, but no EKG changes with Ach

IVUS

Mid LAD myocardial bridge– Length = 38.3mm– Halo thickness = 1.74mm– Systolic compression = 20.9%– MPB = 16%, located 22.8mm proximal

to the MB– MLA = 4.53mm2 in distal LAD

Physiology Testing

Dobutamine dFFR

dFFR = 0.84

How to treat? Testing will identify at least 1 diagnosis in ~75% of patients Treatment varies

– Microvascular dysfunction Nebivolol, ACE-inhibitors, Ranexa

– Vasospasm (epicardial or microvascular) Nitrates, CCB

– Myocardial Bridging Beta-blockers (nebivolol =/- nitrate if concomitant spasm), CCB Surgical unroofing

– Beneficial to endothelium/MB patients Statins Aspirin

All patients should get lifestyle modification—diet, exercise, weight loss, stress reduction

Diagnoses and Treatments

Ford et al. J Am Coll Cardiol 2018;72:2841–55

Diagnosis Improved Outcomes

Surgical unroofing of hemodynamically significant myocardial bridging

Ford et al. Circ Cardiovasc Interv 2019;12:e008126Ford et al. J Am Coll Cardiol Intv 2020;13:33–45Boyd, Tremmel, et al. Ann Thorac Surg 2017;103:1443‐1450

Conclusions Angina + normal cors ≠ MVD Angina + normal cors = INOCA (ANOCA) Symptoms sound pretty typical, stress testing may be normal There are several causes of INOCA/ANOCA

– Microvascular dysfunction (structural or functional)– Endothelial dysfunction/epicardial spasm– Myocardial bridging

Diagnosis typically requires invasive testing Getting a diagnosis guides management and improves outcomes